Although insulin sensitizers such as metformin have long been used to treat PCOS metabolic dysfunction, newer medicines such as incretin mimetics and SGLT2 inhibitors have proven to be more effective at reducing weight and cardiovascular risk. The gene discussed is SLC5A2; the disease is polycystic ovary syndrome.